Where I see patients (1)
My reviews
Selected research
-
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.
Expert opinion on investigational drugs
-
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Blood
-
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement.
Blood advances
Clinical trials
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabt...
Progression free survival is defined as the time from the date of randomization to the date of first documented PD, as defined in the IMWG criteria, or death due to any cause, whichever occurs first
Recruiting
A Study to Evaluate Preventive Treatments for Talquetamab-related Oral Toxicity
Dysgeusia is defined as total WETT score of 25th percentile or below according to the Normative WETT-SA53 percentile table. Taste assessment will be performed using taste strips (WETT). Four concentrations (4=lowest concentration,...
Recruiting
4.9